Lipocine (LPCN) Reports Q3 Loss Per Share of $0.35
Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($0.35), versus ($0.34) reported last year.
For earnings history and earnings-related data on Lipocine (LPCN) click here.
Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($0.35), versus ($0.34) reported last year.
For earnings history and earnings-related data on Lipocine (LPCN) click here.